The Chemours Company

CC

Find Out if You Qualify for a Financial Reward by filling out the form below.

The Chemours Company Form












Stock Fraud Law Center does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024. Among other items, Chemours reported non-GAAP earnings per share of $0.38, missing consensus estimates by $0.20. The Company advised that it “anticipates a low to mid-single digit sequential decline in Net Sales for the third quarter,” citing “[r]esidual impacts from Q2 unplanned downtime at our Altamira, Mexico manufacturing site” in its Titanium Technologies segment; “[r]efrigerant seasonality paired with weaker Freon™ Refrigerants pricing in its Thermal & Specialized Solutions segment; and “[a] continued modest recovery in” its Advanced Performance Materials segment.

Following this news, Chemours’s stock price dropped over 11% on August 2, 2024.

Active Cases

Ticker Symbol Company Name Join Deadline Join
APLT Applied Therapeutics, Inc. February 18, 2025 Join
BIOA BioAge Labs, Inc. March 10, 2025 Join
PCRX Pacira BioSciences, Inc. March 14, 2025 Join
NVO Novo Nordisk A/S March 25, 2025 Join
GO Grocery Outlet Holding Corp. March 31, 2025 Join
NEM Newmont Corporation April 01, 2025 Join
GSK GSK plc April 07, 2025 Join
NTLA Intellia Therapeutics, Inc. April 14, 2025 Join
MRK Merck & Co., Inc. April 14, 2025 Join